Index of reports
> Cases with White Blood Cell Count Decreased (4)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vepesid (Etoposide) where reactions include white blood cell count decreased. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Vepesid side effects in 19 year old female
Reported by a consumer/non-health professional from United States on 2012-08-20
Patient: 19 year old female, weighing 44.0 kg (96.8 pounds)
Reactions: White Blood Cell Count Decreased
Drug(s) suspected as cause:
Ipilimumab
Dosage: cyc 1-4(21 days), cyc 5+ (12wks) 10 mg/kg over 90 min day1. courses:1. last admin: 10aug11
Indication: Bone Sarcoma
Start date: 2011-08-10
Vepesid
Ifosfamide
Possible Vepesid side effects in 19 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20
Patient: 19 year old female, weighing 44.0 kg (96.8 pounds)
Reactions: White Blood Cell Count Decreased, Neoplasm Malignant
Adverse event resulted in: death
Drug(s) suspected as cause:
Vepesid
Ifosfamide
Ipilimumab
Dosage: 10mg/kg iv over 90 min on day 1 last dose on 18oct2011; 470 mg
Indication: Bone Sarcoma
Start date: 2011-08-10
Possible Vepesid side effects in 19 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-16
Patient: 19 year old female, weighing 44.0 kg (96.8 pounds)
Reactions: White Blood Cell Count Decreased
Drug(s) suspected as cause:
Ipilimumab
Dosage: cyc 1-4(21 days), cyc 5+ (12wks) 10 mg/kg over 90 min day1. courses:1. last admin: 10aug11
Indication: Bone Sarcoma
Start date: 2011-08-10
Ifosfamide
Vepesid
Possible Vepesid side effects in 54 year old female
Reported by a physician from Taiwan, Province of China on 2012-04-05
Patient: 54 year old female, weighing 58.4 kg (128.5 pounds)
Reactions: White Blood Cell Count Decreased, Febrile Neutropenia, non-Hodgkin's Lymphoma Recurrent
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytosar-U
Dosage: 3000 mg, 1x/day
Start date: 2012-03-07
End date: 2012-03-07
Vepesid
Dosage: 65 mg, 1x/day
Indication: non-Hodgkin's Lymphoma
Start date: 2012-03-03
End date: 2012-03-07
Inotuzumab Ozogamicin
Dosage: 2.77 mg, cyclic, day 2 of each 28 day cycle
Indication: non-Hodgkin's Lymphoma
Start date: 2012-01-06
End date: 2012-02-03
Rituximab
Dosage: 577.5 mg, cyclic, day 1 of each 28 day cycle
Indication: non-Hodgkin's Lymphoma
Start date: 2012-01-05
End date: 2012-02-02
Solu-Medrol
Dosage: 500 mg, 1x/day
Indication: non-Hodgkin's Lymphoma
Start date: 2012-03-03
End date: 2012-03-07
Abiplatin
Dosage: 40 mg, 1x/day
Indication: non-Hodgkin's Lymphoma
Start date: 2012-03-03
End date: 2012-03-06
Other drugs received by patient: Ultracet; Vitamin B6; Chlorhexidine; Norvasc; Senokot; Aloxi
|